Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-23

FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic Bupropion hydrochloride sustained-release product from Slate Run Pharmaceuticals, LLC. The approval co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)